ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4136
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,433.71
0.15%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Aerovate Therapeutics Inc (AVTE)

  7. Aerovate Therapeutics Inc (AVTE) Noticias

AVTE Aerovate Therapeutics Inc

20.74
0.83 (4.17%)
07 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Aerovate Therapeutics Inc AVTE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.83 4.17% 20.74 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
19.34 19.34 21.335 20.74 19.91
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/6/202416:00EDGAR2Form 8-K - Current report
21/5/202415:15GLOBEAerovate Therapeutics Presents Baseline Data from the Phase..
17/5/202418:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202415:59EDGAR2Form 144 - Report of proposed sale of securities
13/5/202415:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202415:39EDGAR2Form 8-K - Current report
13/5/202415:30GLOBEAerovate Therapeutics Announces First Quarter Financial..
27/3/202408:20GLOBEAerovate Therapeutics to Present Patient Baseline..
25/3/202415:10GLOBEAerovate Therapeutics Announces Full-Year 2023 Financial..
11/3/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:37EDGAR2Form 144 - Report of proposed sale of securities
06/3/202407:00GLOBEAerovate Therapeutics Board of Directors Appoints Habib..
27/2/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202417:38EDGAR2Form 144 - Report of proposed sale of securities
09/2/202415:28EDGAR2Form SC 13G - Statement of acquisition of beneficial..
24/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:29EDGAR2Form 144 - Report of proposed sale of securities
08/1/202416:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202406:59EDGAR2Form 8-K - Current report
29/12/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202316:50EDGAR2Form 144 - Report of proposed sale of securities
22/12/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:24EDGAR2Form 144 - Report of proposed sale of securities
15/12/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202315:10EDGAR2Form 144 - Report of proposed sale of securities
07/12/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202315:13EDGAR2Form 144 - Report of proposed sale of securities
20/11/202315:46EDGAR2Form 8-K - Current report
20/11/202315:45GLOBEAerovate Therapeutics Announces Simultaneous Completion of..
13/11/202307:03EDGAR2Form 8-K - Current report
13/11/202307:00GLOBEAerovate Therapeutics Announces Third Quarter Financial..
03/11/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202313:05EDGAR2Form 144 - Report of proposed sale of securities
14/8/202307:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202307:10EDGAR2Form 8-K - Current report
14/8/202307:00GLOBEAerovate Therapeutics Announces Second Quarter Financial..
09/8/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202310:53EDGAR2Form 144 - Report of proposed sale of securities
11/7/202316:03EDGAR2Form 8-K - Current report
11/7/202316:00GLOBEAerovate Therapeutics Appoints Habib Dable To Its Board of..
07/7/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202314:35EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
AVTE
Aerovate Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados